BeiGene Opens Biologics Manufacturing and Clinical R&D Center

BeiGene opened an $800 million center for biologics manufacturing and research in July of 2024 in Hopewell, N.J. Sited on 42 acres at the Princeton West Innovation Campus, the development provides 400,000 sf of dedicated space for commercial-stage production of cancer therapies. A 100,000-sf lab building accommodates clinical R&D suites and collaborative office settings. As BeiGene's U.S. headquarters and flagship manufacturing facility, the highly flexible complex integrates universal design principles to create an adaptable, human-centric environment.

Ground was broken in April of 2022 on the solar-ready project, which features a heating and cooling system that uses recycled wastewater generated by the treatment plant for the cooling towers. Two of the structures incorporate prefabricated modules that were manufactured off site and transported from the Port of Philadelphia. Integrated Project Services (IPS) served as lead architect and engineer with Meyer as associate architect and DPR Construction as general contractor.